Apr 19, 2024

Featuring perspectives from Dr Natalie S Callander and Dr Paul G Richardson, including the following topics.

• Introduction (0:00)
• Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates in Multiple Myeloma (MM) — Dr Callander (8:25)
• Integration of Other Novel Therapies into...

Apr 19, 2024

Featuring perspectives from Dr Ann S LaCasce, Dr Matthew Lunning, Dr Kami Maddocks and Dr Andrew D Zelenetz, including the following topics.

• Introduction (0:00)
• Follicular Lymphoma (FL) — Dr Zelenetz (2:29)
• Mantle Cell Lymphoma (MCL) — Dr Lunning (32:04)
• Hodgkin Lymphoma (HL) — Dr LaCasce (1:00:36)
• Diffuse...

Apr 12, 2024

Featuring perspectives from Dr Bita Fakhri, including the following topics:

• Overview of select presentations from ASH 2023; recent FDA approval of lisocabtagene maraleucel (0:00)
• 6-year follow-up from the Phase III CLL14 trial of first-line venetoclax/obinutuzumab versus chlorambucil/obinutuzumab for chronic lymphocytic...

Mar 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 2: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Andrew M Evens, DO, MBA, MSc

 
CME information and select...

Mar 27, 2024

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 1: Follicular and Mantle Cell Lymphoma — Sonali M Smith, MD

CME information and select publications